Kalshi is Betting on Trial Results and FDA Decisions Now, What's Next?
FDA Announces 3 Final Guidances to Increase Patient Participation in Oncology Trials
Evis Sala Announces a Landmark Oncology Partnership Between Albania and Italy
RxPONDER Analysis: Ovarian Reserve May Refine Chemotherapy Decisions in HR-Positive Breast Cancer
Wafik El-Deiry: Scientific Freedom and Diverse Thinking Drive Better Medicine
Herbert Loong: Prospective Open-labelled Phase 2 Pembrolizumab in Acral Lentiginous Melanoma
First Chemotherapy Session: What to Expect
SABCS 2026 Male Breast Cancer Advocate Scholarship
